Link Details
- Metabolite
- HMDB0000054 (Bilirubin)
- DrugBank ID
- DB01072
- Drug Name
- Atazanavir
- Effect
- Increase
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Rodriguez-Novoa S, Morello J, Gonzalez M, Vispo E, Barreiro P, Gonzalez-Pardo G, Jimenez-Nacher I, Gonzalez-Lahoz J, Soriano V: Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin. AIDS. 2008 Nov 30;22(18):2535-7. doi: 10.1097/QAD.0b013e3283177f38. [PubMed:19005277 ]
- Rotger M, Taffe P, Bleiber G, Gunthard HF, Furrer H, Vernazza P, Drechsler H, Bernasconi E, Rickenbach M, Telenti A: Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis. 2005 Oct 15;192(8):1381-6. Epub 2005 Sep 9. [PubMed:16170755 ]
- Crutchley RD, Guduru RC, Cheng AM: Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection. HIV AIDS (Auckl). 2016 Mar 9;8:47-65. doi: 10.2147/HIV.S99063. eCollection 2016. [PubMed:27022304 ]
- Krishna R, East L, Larson P, Valiathan C, Deschamps K, Luk JA, Bethel-Brown C, Manthos H, Brejda J, Gartner M: Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose. Biopharm Drug Dispos. 2016 Dec;37(9):533-541. doi: 10.1002/bdd.2043. Epub 2016 Nov 4. [PubMed:27696440 ]